Stockreport

Annexon Biosciences to Participate in Upcoming September Investor Conferences

Annexon, Inc. - common stock  (ANNX) 
PDF BRISBANE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing novel complement therapies for neuroinflammator [Read more]